Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Enzastaurin in Advanced or Metastatic Malignancies
2006-004486-34Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of enzastaurin in Non-hematologic malignancy and cancer, sponsored by Eli Lilly and Company. Started Sep 2006; status: completed.
02
Drugs
enzastaurin
03
Conditions
Non-hematologic malignancycancer
Beyond the preview
Go deeper on 2006-004486-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004486-34.